sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
aacuacuucggcgucuaca | 311 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ggacagcacaugcaucuca | 223 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ugaugucugcuccagugau | 399 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
gccgccugauguuguuacu | 25 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aguuucucucauccaggcc | 438 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aguggcgauugaguacacg | 70 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
gaagcccaacccgcagugu | 249 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uccucucggcguagggcug | 208 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uccagacgaccgccaugau | 150 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aguagcacccccgccgaag | 36 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ugugugccggcuaccgcaa | 391 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ugcacuauggcuuguacaa | 217 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ccaucggaggggacccuca | 361 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ugcagcgaggucuaucgcu | 285 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
agaaguggcgauugaguac | 74 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uccccuacagggccgagua | 115 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
acacccgcaucacaggugu | 313 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ggcagccugauugucucaa | 231 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aaggcacuagauucccggc | 88 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ugaaggacaccucuccagg | 605 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
cuucggcgggggugcuacu | 35 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ugaguacacgcagacugcc | 62 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uguaguaaguucccaggcg | 94 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aucacccagcggucagcga | 396 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
agcgcgaguucugccacac | 270 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aaguaugauuugccgugca | 195 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ggaccccucaccugcuucu | 107 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
acgggcauccuuuuggagu | 32 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
agguggggaaguccugacu | 371 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
cugggaacuuacuacaacu | 97 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uucggaagccccuggucua | 433 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
ggaugugcaguugauccca | 283 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
acgcagacugccugaguac | 56 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uguacccuaggaaauacca | 48 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uuagaccaggggcuuccga | 350 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
cagcugcccuuuggaauaa | 610 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
aggcacuagauucccggcg | 86 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
uugcauuaggcagcagugg | 338 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
agauucccggcggguaaga | 80 | AU2022201595B2 | Compositions and methods for inhibiting expression of tmprss6 gene | 20,250,130 | 3 | [
"AU",
"CN",
"JP",
"US",
"HK",
"MX",
"MO",
"KR",
"SG",
"CA",
"IN",
"BR",
"EP",
"PH",
"WO",
"RU"
] | null |
cucccaauaaagcuggacaag | 129 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cucccaauaaagcuggacaag | 709 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cucccaauaaagcuggacaag | 439 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cucccaauaaagcuggacaag | 717 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uucuuguccagcuuuauugggag | 596 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uucuuguccagcuuuauugggag | 234 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uucuuguccagcuuuauugggag | 710 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uucuuguccagcuuuauugggag | 718 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuaggugagaucuagggaggggu | 648 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuaggugagaucuagggaggggu | 338 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugcaacacagaagucucacgacu | 326 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugcaacacagaagucucacgacu | 636 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
aucugcaacacagaagucucacg | 642 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
aucugcaacacagaagucucacg | 332 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uggaggcuuguuccauguagccc | 601 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uggaggcuuguuccauguagccc | 600 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uggaggcuuguuccauguagccc | 290 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uggaggcuuguuccauguagccc | 291 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucagggaacugaagccaucgguc | 137 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucagggaacugaagccaucgguc | 499 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucagggaacugaagccaucgguc | 138 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucagggaacugaagccaucgguc | 500 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 747 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 702 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 705 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 666 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 704 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 686 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 684 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 688 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 689 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 701 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 692 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 670 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 749 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 754 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 669 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 751 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 746 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 729 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 750 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 733 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 691 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 752 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 15 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 755 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 19 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 663 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 662 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 748 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 753 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 731 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 728 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 664 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 745 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 730 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 732 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 685 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 21 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 667 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 23 | US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | 20,220,809 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.